4/12/2019Luqa Pharma and Ferrer Enter Agreement for Antibiotic Ozenoxacin in G...

4/11/2019Ant Financial Aims to Disrupt China’s Health Insurance Space with Mut...

4/11/2019NHSA Solicits Comments on Draft Rules for Use of Basic Medical Insuran...

4/11/2019CDE Publicizes Six More Drug Applications To Be Granted Priority Revie...

4/11/2019China Plans to Issue A New Set of Standards for Stem Cell Therapies

4/11/2019Synaffix Announces $125M License Agreement with Shanghai Miracogen

4/11/2019Catalent Opens 2nd Shanghai Facility to Optimize Clinical Supply Solut...

4/10/2019HitGen and Kaken Enter into License Agreement for Novel Drug Developme...

4/10/2019ReNeuron Licenses China Rights of Cell Therapy Programs to Fosun Pharm...

4/10/2019NHC Issues Notice on Implementing Drug Consumption Surveillance and Ov...

4/10/2019NDRC Solicits Comments on 2019 Edition of Guiding Catalogue for the Ad...

4/10/2019BioAtla and BeiGene Form Global Collaboration for Novel Conditionally ...

4/10/2019Chongqing Zhifei Bio Halts Production after Delay in License Renewal

4/10/2019Sanofi CEO Pledges More Investment, R&D Facility and 16 New Drugs ...

4/10/2019Sanofi Hopes to Catch Up with Digital Healthcare Service in China

4/10/2019Auction - Pharma Site Closure in XiAn, China (Bid Due by April 12)

4/10/2019Takeda Completes China Business Restructure Following Shire Acquisitio...

4/10/2019Ascentage Announces Clinical Collaboration with Junshi Bio to Evaluate...

4/10/2019Antengene Announces U.S. Subsidiary and Collaboration with the Blumber...

4/10/2019China Improves Healthcare Resource Sharing Thru Increased Cooperation ...

4/5/2019Upcoming Event: Pharma China Annual Forum 2019 (April 9, Shanghai)

4/5/2019NMPA Solicits Comments on New Document on Linked Evaluation and Approv...

4/5/2019Recent Executive Moves

4/4/2019NMPA Issues New Announcement (2019#21) for Clinical Data Self-Inspecti...

4/3/2019Deloitte Report: The Future of Life Sciences and Health Care in Asia P...

4/3/2019Novartis CEO Expects China to Become One of Its Three Top Markets in t...

4/3/2019FDA'S Pazdur Encourages Chinese Companies To Bring Low-Cost PD-1 Drugs...

4/3/2019PharmExec: Use of External Innovation in China

4/3/2019Adlai Nortye Receives NMPA Approval for Phase III Trials of Pelareorep

4/3/2019Sichuan Haisco Acquires Stake in eXithera and Right to Its Novel Anti-...

Page:311/799 Total number of articles:23957: [First][<<] [309] [310] [311] [312] [313] [>>] [End]